William Blair & Company’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,600
| Closed | -$295K | – | 1820 |
|
|
2024
Q4 | $295K | Sell |
1,600
-76
| -5% | -$14K | ﹤0.01% | 1293 |
|
|
2024
Q3 | $330K | Buy |
1,676
+4
| +0.2% | +$788 | ﹤0.01% | 1255 |
|
|
2024
Q2 | $345K | Sell |
1,672
-1,755
| -51% | -$363K | ﹤0.01% | 1219 |
|
|
2024
Q1 | $929K | Sell |
3,427
-37
| -1% | -$10K | ﹤0.01% | 894 |
|
|
2023
Q4 | $819K | Sell |
3,464
-138
| -4% | -$32.6K | ﹤0.01% | 921 |
|
|
2023
Q3 | $706K | Sell |
3,602
-326
| -8% | -$63.9K | ﹤0.01% | 952 |
|
|
2023
Q2 | $826K | Sell |
3,928
-174
| -4% | -$36.6K | ﹤0.01% | 908 |
|
|
2023
Q1 | $828K | Sell |
4,102
-1,002
| -20% | -$202K | ﹤0.01% | 887 |
|
|
2022
Q4 | $1.11M | Buy |
5,104
+213
| +4% | +$46.4K | ﹤0.01% | 793 |
|
|
2022
Q3 | $963K | Sell |
4,891
-1,449
| -23% | -$285K | ﹤0.01% | 825 |
|
|
2022
Q2 | $1.36M | Sell |
6,340
-3,334
| -34% | -$714K | 0.01% | 743 |
|
|
2022
Q1 | $2.75M | Sell |
9,674
-550
| -5% | -$156K | 0.01% | 616 |
|
|
2021
Q4 | $3.85M | Sell |
10,224
-5,012
| -33% | -$1.89M | 0.01% | 551 |
|
|
2021
Q3 | $6.29M | Buy |
15,236
+116
| +0.8% | +$47.9K | 0.02% | 412 |
|
|
2021
Q2 | $5.59M | Sell |
15,120
-165
| -1% | -$61K | 0.02% | 435 |
|
|
2021
Q1 | $4.43M | Buy |
15,285
+5,552
| +57% | +$1.61M | 0.02% | 475 |
|
|
2020
Q4 | $2.43M | Buy |
9,733
+4,198
| +76% | +$1.05M | 0.01% | 598 |
|
|
2020
Q3 | $1.25M | Buy |
5,535
+76
| +1% | +$17.2K | 0.01% | 693 |
|
|
2020
Q2 | $952K | Buy |
5,459
+284
| +5% | +$49.5K | ﹤0.01% | 729 |
|
|
2020
Q1 | $653K | Buy |
5,175
+33
| +0.6% | +$4.16K | ﹤0.01% | 796 |
|
|
2019
Q4 | $785K | Buy |
+5,142
| New | +$785K | ﹤0.01% | 849 |
|
|
2018
Q3 | – | Sell |
-2,779
| Closed | -$312K | – | 1611 |
|
|
2018
Q2 | $312K | Sell |
2,779
-43
| -2% | -$4.83K | ﹤0.01% | 1102 |
|
|
2018
Q1 | $301K | Buy |
2,822
+829
| +42% | +$88.4K | ﹤0.01% | 1070 |
|
|
2017
Q4 | $218K | Buy |
+1,993
| New | +$218K | ﹤0.01% | 1240 |
|